Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > End Stage Renal Disease (ESRD) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

End Stage Renal Disease (ESRD) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-01-10

Pages: 130 Pages

Report ld: 3010246

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.

The report studies End Stage Renal Disease Treatment market including three main methods of treatment: Hemodialysis, Kidney transplant and Peritoneal dialysis.

The global market for End Stage Renal Disease (ESRD) Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease (ESRD) Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of End Stage Renal Disease (ESRD) Treatment by region & country, by Type, and by Application.

The End Stage Renal Disease (ESRD) Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease (ESRD) Treatment.

Market Segmentation

Report Metric
Details
Report Title
End Stage Renal Disease (ESRD) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Market Size Available for Years
2024-2030
Global End Stage Renal Disease (ESRD) Treatment Companies Covered
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Global End Stage Renal Disease (ESRD) Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global End Stage Renal Disease (ESRD) Treatment Market, Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Global End Stage Renal Disease (ESRD) Treatment Market, Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of End Stage Renal Disease (ESRD) Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of End Stage Renal Disease (ESRD) Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of End Stage Renal Disease (ESRD) Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 End Stage Renal Disease (ESRD) Treatment Product Introduction
    1.2 Global End Stage Renal Disease (ESRD) Treatment Market Size Forecast
    1.3 End Stage Renal Disease (ESRD) Treatment Market Trends & Drivers
        1.3.1 End Stage Renal Disease (ESRD) Treatment Industry Trends
        1.3.2 End Stage Renal Disease (ESRD) Treatment Market Drivers & Opportunity
        1.3.3 End Stage Renal Disease (ESRD) Treatment Market Challenges
        1.3.4 End Stage Renal Disease (ESRD) Treatment Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global End Stage Renal Disease (ESRD) Treatment Players Revenue Ranking (2023)
    2.2 Global End Stage Renal Disease (ESRD) Treatment Revenue by Company (2019-2024)
    2.3 Key Companies End Stage Renal Disease (ESRD) Treatment Manufacturing Base Distribution and Headquarters
    2.4 Key Companies End Stage Renal Disease (ESRD) Treatment Product Offered
    2.5 Key Companies Time to Begin Mass Production of End Stage Renal Disease (ESRD) Treatment
    2.6 End Stage Renal Disease (ESRD) Treatment Market Competitive Analysis
        2.6.1 End Stage Renal Disease (ESRD) Treatment Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by End Stage Renal Disease (ESRD) Treatment Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Treatment as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Hemodialysis
        3.1.2 Peritoneal Dialysis
        3.1.3 Kidney Transplantation
    3.2 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type
        3.2.1 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global End Stage Renal Disease (ESRD) Treatment Sales Value, by Type (2019-2030)
        3.2.3 Global End Stage Renal Disease (ESRD) Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Kidney Dialysis Centers
        4.1.3 At Homes
        4.1.4 Others
    4.2 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application
        4.2.1 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global End Stage Renal Disease (ESRD) Treatment Sales Value, by Application (2019-2030)
        4.2.3 Global End Stage Renal Disease (ESRD) Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region
        5.1.1 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2019-2024)
        5.1.3 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2025-2030)
        5.1.4 Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        5.2.2 North America End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        5.3.2 Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        5.4.2 Asia Pacific End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        5.5.2 South America End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        5.6.2 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value
    6.3 United States
        6.3.1 United States End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.3.2 United States End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.4.2 Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.5.2 China End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.5.3 China End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.6.2 Japan End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.7.2 South Korea End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.8.2 Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India End Stage Renal Disease (ESRD) Treatment Sales Value, 2019-2030
        6.9.2 India End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
        6.9.3 India End Stage Renal Disease (ESRD) Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Fresenius
        7.1.1 Fresenius Profile
        7.1.2 Fresenius Main Business
        7.1.3 Fresenius End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.1.4 Fresenius End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.1.5 Fresenius Recent Developments
    7.2 DaVita
        7.2.1 DaVita Profile
        7.2.2 DaVita Main Business
        7.2.3 DaVita End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.2.4 DaVita End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.2.5 DaVita Recent Developments
    7.3 Baxter
        7.3.1 Baxter Profile
        7.3.2 Baxter Main Business
        7.3.3 Baxter End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.3.4 Baxter End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.3.5 Nipro Recent Developments
    7.4 Nipro
        7.4.1 Nipro Profile
        7.4.2 Nipro Main Business
        7.4.3 Nipro End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.4.4 Nipro End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.4.5 Nipro Recent Developments
    7.5 B. Braun
        7.5.1 B. Braun Profile
        7.5.2 B. Braun Main Business
        7.5.3 B. Braun End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.5.4 B. Braun End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.5.5 B. Braun Recent Developments
    7.6 Asahi Kasei
        7.6.1 Asahi Kasei Profile
        7.6.2 Asahi Kasei Main Business
        7.6.3 Asahi Kasei End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.6.4 Asahi Kasei End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.6.5 Asahi Kasei Recent Developments
    7.7 Nikkiso
        7.7.1 Nikkiso Profile
        7.7.2 Nikkiso Main Business
        7.7.3 Nikkiso End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.7.4 Nikkiso End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.7.5 Nikkiso Recent Developments
    7.8 WEGO
        7.8.1 WEGO Profile
        7.8.2 WEGO Main Business
        7.8.3 WEGO End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.8.4 WEGO End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.8.5 WEGO Recent Developments
    7.9 Newsol
        7.9.1 Newsol Profile
        7.9.2 Newsol Main Business
        7.9.3 Newsol End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.9.4 Newsol End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.9.5 Newsol Recent Developments
    7.10 Mayo Clinic
        7.10.1 Mayo Clinic Profile
        7.10.2 Mayo Clinic Main Business
        7.10.3 Mayo Clinic End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.10.4 Mayo Clinic End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.10.5 Mayo Clinic Recent Developments
    7.11 Guangdong Biolight
        7.11.1 Guangdong Biolight Profile
        7.11.2 Guangdong Biolight Main Business
        7.11.3 Guangdong Biolight End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.11.4 Guangdong Biolight End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.11.5 Guangdong Biolight Recent Developments
    7.12 Medtronic
        7.12.1 Medtronic Profile
        7.12.2 Medtronic Main Business
        7.12.3 Medtronic End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.12.4 Medtronic End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.12.5 Medtronic Recent Developments
    7.13 Sanxin Medtec
        7.13.1 Sanxin Medtec Profile
        7.13.2 Sanxin Medtec Main Business
        7.13.3 Sanxin Medtec End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.13.4 Sanxin Medtec End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.13.5 Sanxin Medtec Recent Developments
    7.14 Jafron Biomedical
        7.14.1 Jafron Biomedical Profile
        7.14.2 Jafron Biomedical Main Business
        7.14.3 Jafron Biomedical End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.14.4 Jafron Biomedical End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.14.5 Jafron Biomedical Recent Developments
    7.15 SWS Hemodialysis Care
        7.15.1 SWS Hemodialysis Care Profile
        7.15.2 SWS Hemodialysis Care Main Business
        7.15.3 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.15.4 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.15.5 SWS Hemodialysis Care Recent Developments
    7.16 Tianyi Medical
        7.16.1 Tianyi Medical Profile
        7.16.2 Tianyi Medical Main Business
        7.16.3 Tianyi Medical End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
        7.16.4 Tianyi Medical End Stage Renal Disease (ESRD) Treatment Revenue (US$ Million) & (2019-2024)
        7.16.5 Tianyi Medical Recent Developments

8 Industry Chain Analysis
    8.1 End Stage Renal Disease (ESRD) Treatment Industrial Chain
    8.2 End Stage Renal Disease (ESRD) Treatment Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 End Stage Renal Disease (ESRD) Treatment Sales Model
        8.5.2 Sales Channel
        8.5.3 End Stage Renal Disease (ESRD) Treatment Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. End Stage Renal Disease (ESRD) Treatment Market Trends
    Table 2. End Stage Renal Disease (ESRD) Treatment Market Drivers & Opportunity
    Table 3. End Stage Renal Disease (ESRD) Treatment Market Challenges
    Table 4. End Stage Renal Disease (ESRD) Treatment Market Restraints
    Table 5. Global End Stage Renal Disease (ESRD) Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies End Stage Renal Disease (ESRD) Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies End Stage Renal Disease (ESRD) Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of End Stage Renal Disease (ESRD) Treatment
    Table 10. Global End Stage Renal Disease (ESRD) Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global End Stage Renal Disease (ESRD) Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global End Stage Renal Disease (ESRD) Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global End Stage Renal Disease (ESRD) Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global End Stage Renal Disease (ESRD) Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Fresenius Basic Information List
    Table 32. Fresenius Description and Business Overview
    Table 33. Fresenius End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Fresenius (2019-2024)
    Table 35. Fresenius Recent Developments
    Table 36. DaVita Basic Information List
    Table 37. DaVita Description and Business Overview
    Table 38. DaVita End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of DaVita (2019-2024)
    Table 40. DaVita Recent Developments
    Table 41. Baxter Basic Information List
    Table 42. Baxter Description and Business Overview
    Table 43. Baxter End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Baxter (2019-2024)
    Table 45. Baxter Recent Developments
    Table 46. Nipro Basic Information List
    Table 47. Nipro Description and Business Overview
    Table 48. Nipro End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Nipro (2019-2024)
    Table 50. Nipro Recent Developments
    Table 51. B. Braun Basic Information List
    Table 52. B. Braun Description and Business Overview
    Table 53. B. Braun End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of B. Braun (2019-2024)
    Table 55. B. Braun Recent Developments
    Table 56. Asahi Kasei Basic Information List
    Table 57. Asahi Kasei Description and Business Overview
    Table 58. Asahi Kasei End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Asahi Kasei (2019-2024)
    Table 60. Asahi Kasei Recent Developments
    Table 61. Nikkiso Basic Information List
    Table 62. Nikkiso Description and Business Overview
    Table 63. Nikkiso End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Nikkiso (2019-2024)
    Table 65. Nikkiso Recent Developments
    Table 66. WEGO Basic Information List
    Table 67. WEGO Description and Business Overview
    Table 68. WEGO End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of WEGO (2019-2024)
    Table 70. WEGO Recent Developments
    Table 71. Newsol Basic Information List
    Table 72. Newsol Description and Business Overview
    Table 73. Newsol End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Newsol (2019-2024)
    Table 75. Newsol Recent Developments
    Table 76. Mayo Clinic Basic Information List
    Table 77. Mayo Clinic Description and Business Overview
    Table 78. Mayo Clinic End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Mayo Clinic (2019-2024)
    Table 80. Mayo Clinic Recent Developments
    Table 81. Guangdong Biolight Basic Information List
    Table 82. Guangdong Biolight Description and Business Overview
    Table 83. Guangdong Biolight End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Guangdong Biolight (2019-2024)
    Table 85. Guangdong Biolight Recent Developments
    Table 86. Medtronic Basic Information List
    Table 87. Medtronic Description and Business Overview
    Table 88. Medtronic End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Medtronic (2019-2024)
    Table 90. Medtronic Recent Developments
    Table 91. Sanxin Medtec Basic Information List
    Table 92. Sanxin Medtec Description and Business Overview
    Table 93. Sanxin Medtec End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Sanxin Medtec (2019-2024)
    Table 95. Sanxin Medtec Recent Developments
    Table 96. Jafron Biomedical Basic Information List
    Table 97. Jafron Biomedical Description and Business Overview
    Table 98. Jafron Biomedical End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Jafron Biomedical (2019-2024)
    Table 100. Jafron Biomedical Recent Developments
    Table 101. SWS Hemodialysis Care Basic Information List
    Table 102. SWS Hemodialysis Care Description and Business Overview
    Table 103. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of SWS Hemodialysis Care (2019-2024)
    Table 105. SWS Hemodialysis Care Recent Developments
    Table 106. Tianyi Medical Basic Information List
    Table 107. Tianyi Medical Description and Business Overview
    Table 108. Tianyi Medical End Stage Renal Disease (ESRD) Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in End Stage Renal Disease (ESRD) Treatment Business of Tianyi Medical (2019-2024)
    Table 110. Tianyi Medical Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. End Stage Renal Disease (ESRD) Treatment Downstream Customers
    Table 114. End Stage Renal Disease (ESRD) Treatment Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. End Stage Renal Disease (ESRD) Treatment Product Picture
    Figure 2. Global End Stage Renal Disease (ESRD) Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. End Stage Renal Disease (ESRD) Treatment Report Years Considered
    Figure 5. Global End Stage Renal Disease (ESRD) Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by End Stage Renal Disease (ESRD) Treatment Revenue in 2023
    Figure 7. End Stage Renal Disease (ESRD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hemodialysis Picture
    Figure 9. Peritoneal Dialysis Picture
    Figure 10. Kidney Transplantation Picture
    Figure 11. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global End Stage Renal Disease (ESRD) Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Kidney Dialysis Centers
    Figure 15. Product Picture of At Homes
    Figure 16. Product Picture of Others
    Figure 17. Global End Stage Renal Disease (ESRD) Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global End Stage Renal Disease (ESRD) Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions End Stage Renal Disease (ESRD) Treatment Sales Value (%), (2019-2030)
    Figure 30. United States End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 36. China End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 38. China End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. India End Stage Renal Disease (ESRD) Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India End Stage Renal Disease (ESRD) Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. India End Stage Renal Disease (ESRD) Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. End Stage Renal Disease (ESRD) Treatment Industrial Chain
    Figure 52. End Stage Renal Disease (ESRD) Treatment Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.

The report studies End Stage Renal Disease Treatment market including three main methods of treatment: Hemodialysis, Kidney transplant and Peritoneal dialysis.

Market Segmentation

Related Reports

Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2024
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Published: 2024-01-12
Pages: 90
USD 2900.00
(Single User License)
Global End Stage Renal Disease (ESRD) Treatment Market Insights, Forecast to 2030
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Published: 2024-04-12
Pages: 119
USD 4900.00
(Single User License)
Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2025
The global market for End Stage Renal Disease (ESRD) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 99
USD 2900.00
(Single User License)
Global End Stage Renal Disease (ESRD) Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031
The global End Stage Renal Disease (ESRD) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 147
USD 4900.00
(Single User License)
Global End Stage Renal Disease (ESRD) Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global End Stage Renal Disease (ESRD) Treatment market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)

Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2024
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Published: 2024-01-12
Pages: 90
USD 2900.00 ()
Global End Stage Renal Disease (ESRD) Treatment Market Insights, Forecast to 2030
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Published: 2024-04-12
Pages: 119
USD 4900.00 ()
Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2025
The global market for End Stage Renal Disease (ESRD) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 99
USD 2900.00 ()
Global End Stage Renal Disease (ESRD) Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031
The global End Stage Renal Disease (ESRD) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 147
USD 4900.00 ()
Global End Stage Renal Disease (ESRD) Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global End Stage Renal Disease (ESRD) Treatment market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
USD 4250.00 ()